ifosfamide has been researched along with Carcinoma, Ovarian Epithelial in 2 studies
Carcinoma, Ovarian Epithelial: A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this phase II study was to investigate the efficacy and toxicity of combined ifosfamide and cisplatin chemotherapy in patients with recurrent epithelial ovarian cancer (EOC)." | 5.17 | Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer. ( Bae, DS; Choi, CH; Kim, BG; Kim, MK; Kim, TJ; Lee, JW; Lee, YY; Song, T, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Song, T | 1 |
| Kim, MK | 1 |
| Lee, YY | 1 |
| Choi, CH | 1 |
| Kim, TJ | 1 |
| Lee, JW | 1 |
| Kim, BG | 1 |
| Bae, DS | 1 |
| Lee, M | 1 |
| Kim, SW | 1 |
| Nam, EJ | 1 |
| Cho, H | 1 |
| Kim, JH | 1 |
| Kim, YT | 1 |
| Kim, S | 1 |
1 trial available for ifosfamide and Carcinoma, Ovarian Epithelial
| Article | Year |
|---|---|
Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ovarian Epithelial; Cisplati | 2013 |
1 other study available for ifosfamide and Carcinoma, Ovarian Epithelial
| Article | Year |
|---|---|
ATP-based chemotherapy response assay in primary or recurrent ovarian and peritoneal cancer.
Topics: Adenocarcinoma, Clear Cell; Adenosine Triphosphate; Adult; Aged; Antineoplastic Combined Chemotherap | 2014 |